| Literature DB >> 18412165 |
Jianfei Yang1, Min Yang, Tin Min Htut, Xinshou Ouyang, Adedayo Hanidu, Xiang Li, Rosemarie Sellati, Huiping Jiang, Shu Zhang, Hongxing Li, Jie Zhao, Adrian T Ting, Lloyd Mayer, Jay C Unkeless, Mark E Labadia, Martin Hodge, Jun Li, Huabao Xiong.
Abstract
Epstein-Barr virus-induced gene 3 (EBI3) associates with p28 to form IL-27 and with IL-12p35 to form IL-35. IL-27Ralpha(-/-) mice studies indicate that IL-27 negatively regulates Th17 cell differentiation. However, no EBI3, p28 or p35-deficiency studies that directly address the role of EBI3, p28 or p35 on Th17 cells have been done. Here, we demonstrate that spleen cells derived from EBI3(-/-) mice produce significantly higher levels of IL-17 as well as IL-22 upon stimulation with OVA. In vitro derived EBI3(-/-) Th17 cells also produced significantly higher levels of IL-17 and IL-22 than WT cells. The frequency of IL-17-producing cells was also elevated when EBI3(-/-) cells were cultured under Th17 conditions. In addition, spleen cells from EBI3(-/-) mice immunized with Listeria monocytogenes produced significantly elevated levels of IL-17 and IL-22. Furthermore, the Th17 transcription factor RORgamma t was significantly enhanced in EBI3(-/-) cells. Finally, EBI3(-/-) mice exhibited a reduced bacterial load following an acute challenge with L. monocytogenes or a re-challenge of previously immunized mice, suggesting that EBI3 negatively regulates both innate and adaptive immunity. Taken together, these data provide direct evidence that EBI3 negatively regulates the expression of IL-17, IL-22 and RORgamma t as well as protective immunity against L. monocytogenes.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18412165 PMCID: PMC2989250 DOI: 10.1002/eji.200838145
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532